MASS 908 Devices Corporation: Market Capitalization to Book Value Ratio

908 Devices (MASS) - corporate logo

This chart illustrates that the market value of 908 Devices Inc. (MASS) is 3.53, while the business develops mobile mass spectrometers featuring AI analysis on robotic assembly lines. Massachusetts-based assembly is supported by climate control and a strategic chip reserve. High sales margins are offset by significant R&D and logistics expenses, which constrain rapid gains in operational efficiency due to the customized nature of production.

MASS (908 Devices Corporation) Market Capitalization to Book Value history from 07/04/2022 to 10/27/2026
Product sample of 908 Devices Corp

High-tech production of mass spectrometers utilizing AI and robotics drives the P/BV multiple dynamics, reflecting the market value of the intellectual capital of 908 Devices Inc. (MASS). The current value of 3.53 demonstrates the ratio of market capitalization to net book assets, allowing investors to assess the premium paid for the business relative to its actual tangible asset base and determine the level of the premium for technological superiority.

Direct competitors

Abbott Laboratories - Market Value to Book Value Ratio|thermofisher.com (TMO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio GE HealthCare Technologies (GEHC)|Capitalization to Book Value Ratio Mettler-Toledo|WAT (Waters Corp.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Bio-Techne Inc. (TECH)|Market Capitalization to Book Value Ratio BRKR (Bruker Corporation)|Market Capitalization to Book Value Ratio azenta.com AZTA|Market Capitalization to Book Value Ratio VREX|SMLR: Market Value to Equity Ratio|Market Value to Book Value Ratio Butterfly iQ|MLAB (Mesa Laboratories Corp.) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio QSI (Quantum-Si)|Market-to-Book Ratio NNOX|QTRX (Quanterix) - Market Value to Book Value Ratio|Market Capitalization to Book Value capsovision.com CV|Market Cap to Net Assets Ratio MaxCyte, Inc (MXCT)|Market Cap to Book Value Multiple Rapid Micro Biosystems Inc. RPID|Market Capitalization to Book Value Ratio SEER (Seer, Inc.)|HYPR - Market Capitalization to Book Value|FONR (FONAR) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Daxor|MDAI - Market Cap to Net Assets Ratio|Market Value to Book Value VIVS|Market Value to Book Value Ratio ACON (Aclarion)|Market Cap to Net Assets Ratio akoyabio.com (AKYA)|THMO: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Market Capitalization to Book Value Ratio